<DOC>
	<DOCNO>NCT01720160</DOCNO>
	<brief_summary>The purpose research study show whether Neo system safe work people heart failure . The study currently long-term follow .</brief_summary>
	<brief_title>Barostim HOPE4HF ( Hope Heart Failure ) Study</brief_title>
	<detailed_description>A prospective , randomize study describe safety efficacy Neo system approximately 60 heart failure subject leave ventricular ejection fraction equal le 35 percent .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Age 21 year . On optimal , guidelinedirected ( per American Heart Association/American College Cardiology guideline ) , stable , heartfailure medication dose least 4 week prior screen . Known suspected baroreflex failure autonomic neuropathy . Myocardial infarction , unstable angina , syncope , cerebral vascular accident , sudden cardiac death ( SCD ) , receive defibrillation therapy within 3 month . Heart failure secondary reversible cause treatable condition .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>